AstraZeneca posts MITCHELL asthma results; registers AZD6234 Phase 3 SELENE 2Aug 27Weekly roundup, 7 itemsAstraZenecaAZD4144
AstraZeneca adds fourth trial: Phase 3 AZD6234 in obesity, adjunct to incretinsAug 21Weekly roundup, 4 itemsAstraZenecaAZD0292
Sign inSign in